All News #Library
Biotech
Sydnexis To Unveil Phase 3 STAR Trial Data On SYD-101 At ARVO
02 May 2026 //
PHARMIWEB
Sydnexis Presents SYD-101 Phase 3 Data at 2026 AAPOS Meeting
23 Mar 2026 //
PHARMIWEB
UK Approves Santen`s Ryjunea for Slowing Childhood Myopia
06 Nov 2025 //
BUSINESS WIRE
Sydnexis Gets FDA CRL On SYD-101 For Pediatric Myopia
23 Oct 2025 //
BUSINESSWIRE

Market Place
Sourcing Support